✦ LIBER ✦

PCN82 Cost-Effectiveness Analysis of Trastuzumab + Docetaxel Versus Docetaxel Alone in the Treatment of HER2+ Metastatic Breast Cancer

✍ Scribed by Athanasakis, K.; Golna, C.; Kyriopoulos, J.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Trastuzumab (Herceptin®) plus docetaxel

✍ J.M Extra; F Cognetti; D Maranichi; R Snyder; L Mauriac; M Tubiana-Hulin; S Chan 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 348 KB

PCN92 COST-EFECTIVENESS ANALYSIS OF DOCE

✍ C Tenorio; J Vargas; J Martínez; Á Paladio 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 83 KB

PCN50 COST-EFFECTIVENESS OF DOCETAXEL PL

✍ S Jones; L Chen; M Tangirala; L Asmar; P Airia; MF Thompson 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 87 KB

PCN21 SYSTEMATIC REVIEW OF COST-EFFECTIV

✍ OA Le 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 71 KB

PCN16 COST-EFFECTIVENESS ANALYSIS OF ADJ

✍ TY Chao; SC Chen; KJ Chang; HK Chang; DR Chen; MF Hou; RK Hsieh; WT Huang; LM Ts 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 71 KB

Randomized phase III trial of trastuzuma

✍ Kenichi Inoue; Kazuhiko Nakagami; Mitsuhiro Mizutani; Yasuo Hozumi; Yasuhiro Fuj 📂 Article 📅 2009 🏛 Springer US 🌐 English ⚖ 368 KB